Some pre-clinical studies have suggested inferior outcomes when treated with a combination of ketogenic diets and PI3K inhibitors, such as increased tumor growth in some cancers; thus, ketogenic diets are currently not recommended (8). Here, PIK3CA is linked to cancer.